<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03707860</url>
  </required_header>
  <id_info>
    <org_study_id>18 KHCC 86</org_study_id>
    <nct_id>NCT03707860</nct_id>
  </id_info>
  <brief_title>Radiation Oncology Mobile Application</brief_title>
  <acronym>Î³-App</acronym>
  <official_title>Radiation Oncology Mobile Application: Symptoms Reporting System and Quality Assurance Tool</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Hussein Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Hussein Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To develop a novel a mobile phone application (available on Android and IOS) for patients
      receiving radiation treatment for head and neck cancer. Through this application, patients
      will get access to their treatment calender, through a system connected with Mosiac database,
      which provides a timely and precise access to their treatments schedule.

      In addition, patients will be able to report their treatment related toxicity in real time
      fashion, these symptoms will be addressed daily instead of the weekly floor clinic checks.

      Furthermore, the radiation oncologist will receive an instant notification through the
      application, if there is error in patient's treatment (missing field, wrong dose, etc..)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Grade of symptoms improved with early intervention.</measure>
    <time_frame>only during RT (7WEEKS)</time_frame>
    <description>using CTCAE v.5</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>compliance on the mobile.</measure>
    <time_frame>Only during RT (7WEEKS)</time_frame>
    <description>number of reports.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Head and Neck Cancer</condition>
  <condition>Radiation Toxicity</condition>
  <arm_group>
    <arm_group_label>head and neck radiotherapy patients</arm_group_label>
    <description>(Single arm); Patients receiving radiotherapy for head and neck cancers can report their symptoms through the mobile app.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients referred to our radiation oncology clinic with head and neck cancer.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Adult patients receiving definitive or adjuvant RT to head and neck site Chemotherapy is
        allowed PS:0-1 Has a smart phone

        Exclusion Criteria:

        Poor performance early laryngeal cancer Patient with metastatic disease, or palliative
        intent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ramiz Abu-Hijlih, MD</last_name>
    <phone>+962791570957</phone>
    <email>rhijlih@khcc.jo</email>
  </overall_contact>
  <location>
    <facility>
      <name>King Hussein Cancer Center</name>
      <address>
        <city>Amman</city>
        <zip>11941</zip>
        <country>Jordan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ramiz AbuHijlih, MD</last_name>
      <phone>065300460</phone>
      <email>rhijlih@khcc.jo</email>
    </contact>
    <contact_backup>
      <last_name>Farah Zahran, MSc</last_name>
      <phone>+96265300460</phone>
      <email>fzahran@khcc.jo</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Jordan</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 12, 2018</study_first_submitted>
  <study_first_submitted_qc>October 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2018</study_first_posted>
  <last_update_submitted>March 1, 2020</last_update_submitted>
  <last_update_submitted_qc>March 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>King Hussein Cancer Center</investigator_affiliation>
    <investigator_full_name>Ramiz Abu-Hijlih</investigator_full_name>
    <investigator_title>Consultant Radiation Oncology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

